Naproxen is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Apotheca Inc.. The primary component is Naproxen.
Product ID | 12634-684_27fec1d8-54db-4fed-e054-00144ff88e88 |
NDC | 12634-684 |
Product Type | Human Prescription Drug |
Proprietary Name | Naproxen |
Generic Name | Naproxen |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2007-07-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA078250 |
Labeler Name | Apotheca Inc. |
Substance Name | NAPROXEN |
Active Ingredient Strength | 500 mg/1 |
Pharm Classes | Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2007-07-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA078250 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-07-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA078250 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-07-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA078250 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-07-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA078250 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-07-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA078250 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-07-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA078250 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-07-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA078250 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-07-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA078250 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-07-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA078250 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-07-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA078250 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-07-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA078250 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-07-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA078250 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-07-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA078250 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-07-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA078250 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-07-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA078250 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-07-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA078250 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-07-01 |
Marketing End Date | 2015-12-28 |
Marketing Category | ANDA |
Application Number | ANDA078250 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-07-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA078250 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-07-01 |
Inactivation Date | 2020-01-31 |
Marketing Category | ANDA |
Application Number | ANDA078250 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2015-12-28 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
NAPROXEN | 500 mg/1 |
SPL SET ID: | 27ab4f1a-2f2b-150c-e054-00144ff8d46c |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
PHarm Class EPC | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
0054-3630 | Naproxen | Naproxen |
0093-1005 | Naproxen | Naproxen |
0093-1006 | Naproxen | Naproxen |
0143-1346 | Naproxen | Naproxen |
0143-1347 | Naproxen | Naproxen |
0143-1348 | Naproxen | Naproxen |
0143-9908 | NAPROXEN | naproxen sodium |
0143-9916 | NAPROXEN | naproxen sodium |
0179-1978 | Naproxen | Naproxen |
0440-1852 | Naproxen | Naproxen |
0440-7852 | Naproxen | Naproxen |
0615-1504 | Naproxen | Naproxen |
0615-3562 | Naproxen | Naproxen |
0615-3563 | Naproxen | Naproxen |
0615-7709 | Naproxen | Naproxen |
0615-7892 | Naproxen | Naproxen |
0615-8094 | Naproxen | Naproxen |
10544-010 | Naproxen | Naproxen |
10544-016 | Naproxen | Naproxen |
10544-019 | Naproxen | Naproxen |
10544-044 | Naproxen | Naproxen |
10544-061 | Naproxen | Naproxen |
10544-111 | NAPROXEN | NAPROXEN |
10544-277 | Naproxen | Naproxen |
10544-278 | Naproxen | Naproxen |
10544-614 | NAPROXEN | naproxen sodium |
10544-920 | Naproxen | Naproxen |
10544-922 | Naproxen | Naproxen |
10544-939 | Naproxen | Naproxen |
12634-498 | Naproxen | Naproxen |
68071-3092 | Naproxen | Naproxen |
68071-4006 | NAPROXEN | NAPROXEN |
68071-3029 | naproxen | naproxen |
68071-3066 | naproxen | naproxen |
68071-3387 | Naproxen | Naproxen |
68071-3345 | NAPROXEN | NAPROXEN |
68071-4510 | NAPROXEN | NAPROXEN |
68071-4381 | NAPROXEN | NAPROXEN |
68134-201 | Naproxen | Naproxen |
68151-2894 | Naproxen | Naproxen |
68151-2609 | Naproxen | Naproxen |
68151-2895 | Naproxen | Naproxen |
68382-012 | Naproxen | Naproxen |
68382-013 | Naproxen | Naproxen |
68382-014 | Naproxen | Naproxen |
68387-800 | Naproxen | Naproxen |
68387-801 | Naproxen | Naproxen |
68387-802 | Naproxen | Naproxen |
68462-190 | Naproxen | Naproxen |
68462-189 | Naproxen | Naproxen |